Respiratory Diagnostics Market by Product, Test Type, Indication, End-User - Global Forecast 2025-2030- Product Image

Sale

Respiratory Diagnostics Market by Product, Test Type, Indication, End-User - Global Forecast 2025-2030

Report
195 Pages
October 2024
Region: Global
360iResearch™
ID: 5914461

UP TO €667EUR$697USD£555GBP OFF until Dec 31^st 2024

The Respiratory Diagnostics Market grew from USD 6.12 billion in 2023 to USD 6.66 billion in 2024. It is expected to continue growing at a CAGR of 8.67%, reaching USD 10.96 billion by 2030.

The respiratory diagnostics market encompasses tools and techniques used to identify respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), tuberculosis, and lung cancer. Advances in technology and an aging population necessitate the continual development of this market, as these factors increase the demand for accurate, efficient, and non-invasive diagnostic procedures. Applications in the medical field range from hospitals and clinical laboratories to homecare settings, driven by both preventive healthcare and chronic disease management, thereby broadening the market's end-use scope. A key influencing growth factor in this market is the rising prevalence of respiratory diseases due to pollution, smoking, and lifestyle changes, alongside greater awareness and government initiatives for early diagnosis. Opportunities arise from integrating artificial intelligence and machine learning into diagnostic devices to enhance accuracy and reduce time. Companies can leverage digital platforms offering remote diagnostics, especially as telemedicine becomes more prevalent. However, limiting challenges include high costs associated with advanced diagnostic tools and a lack of skilled professionals in certain regions, which can hinder widespread adoption. Stringent regulations and reimbursement issues might also impede growth. Encouraging innovation lies in developing cost-effective, portable diagnostic solutions and focusing on personalized medicine, aiming to meet individual patient needs. For research advancements, opportunities exist in biomarker discovery and nanotechnology applications to improve early detection and monitoring systems. Given the dynamic evolution and competition within the respiratory diagnostics market, firms are recommended to invest in strategic partnerships, acquisition of emerging technologies, and continuous market monitoring to adapt swiftly to changing needs. The nature of the market is competitive, with players focusing on expanding their product portfolios and strengthening their global presence to capture emerging opportunities in developing regions with rising healthcare infrastructures.

Understanding Market Dynamics in the Respiratory Diagnostics Market

The Respiratory Diagnostics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing aging population with susceptibility to chronic respiratory diseases
- Growth in the approvals for respiratory disease diagnostic kits, tests, and systems
- Rising preferences for remote and home care testing devices
Market Restraints
- Incidences of product recall of respiratory diagnosis panels and kits with limited reimbursement policies
Market Opportunities
- Technological advancements to introduce sophisticated respiratory diagnostic tools
- Government initiatives and funding for respiratory diagnostic tools
Market Challenges
- Risk of errors associated with complex diagnostic procedures

Exploring Porter’s Five Forces for the Respiratory Diagnostics Market

Porter’s Five Forces framework further strengthens the insights of the Respiratory Diagnostics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Respiratory Diagnostics Market

External macro-environmental factors deeply influence the performance of the Respiratory Diagnostics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Respiratory Diagnostics Market

The Respiratory Diagnostics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Respiratory Diagnostics Market

The Respiratory Diagnostics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Respiratory Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Adaltis S.r.l., Masimo Corporation, Merck KGaA, Somnoware by ResMed Corp., ProAxsis by NetScientific PLC, Medtronic PLC, Hologic, Inc., F. Hoffmann-La Roche Ltd., Quest Diagnostics Incorporated, Becton, Dickinson, and Company, Seegene Inc., Siemens Healthineers AG, Abbott Laboratories, Vitalograph Ltd., Bioneer Corporation, Altona Diagnostics GmbH, CerTest Biotec S.L., GE HealthCare Technologies, Inc., Drägerwerk AG & Co. KGaA, Quidel Corporation, Daan Gene Co., Ltd., bioMérieux S.A., SDI Diagnostics, Inc., Koninklijke Philips N.V., Bio-Rad Laboratories, Inc., Sansure Biotech Inc., Johnson & Johnson Services, Inc., Thermo Fisher Scientific Inc., ZeptoMetrix LLC, and Diatech Pharmacogenetics srl.

Market Segmentation & Coverage

This research report categorizes the Respiratory Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Assays & Reagents
- Instruments & Devices
- Software & Services
Test Type
- Imaging Tests
  - Computed Tomography
  - Magnetic Resonance Imaging
  - Positron Emission Tomography
  - X-Ray
- Mechanical Tests
  - Peak Flow Test
  - Pulmonary Function Tests
  - Spirometry
- Molecular Diagnostic Tests
  - DNA Sequencing & Next-Generation Sequencing
  - In Situ Hybridization
  - Microarrays
  - Nucleic Acid Amplification Test
  - PCR
- OSA Diagnostic Tests
- Traditional Diagnostic Tests
  - Biochemical Tests
  - Immunodiagnostics
  - Microscopy
Indication
- Asthma
- Chronic Obstructive Pulmonary Disease
- Lung Cancer
- Pneumonia
- Tuberculosis
End-User
- Diagnostic Laboratories
- Hospitals & Clinics
- Research Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing aging population with susceptibility to chronic respiratory diseases
5.1.1.2. Growth in the approvals for respiratory disease diagnostic kits, tests, and systems
5.1.1.3. Rising preferences for remote and home care testing devices
5.1.2. Restraints
5.1.2.1. Incidences of product recall of respiratory diagnosis panels and kits with limited reimbursement policies
5.1.3. Opportunities
5.1.3.1. Technological advancements to introduce sophisticated respiratory diagnostic tools
5.1.3.2. Government initiatives and funding for respiratory diagnostic tools
5.1.4. Challenges
5.1.4.1. Risk of errors associated with complex diagnostic procedures
5.2. Market Segmentation Analysis
5.2.1. Product: Need for rapid detection of pathogens driving the adoption of assays and reagents
5.2.2. Test Type: Research initiatives to advance the accuracy and specificity of molecular diagnostic tests
5.2.3. Indication: Need for advanced respiratory diagnostic technologies to attain accurate testing of chronic obstructive pulmonary disease
5.2.4. End-User: Adoption of a diverse range of diagnostic tools in hospitals and clinics for identifying and monitoring respiratory ailments
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Respiratory Diagnostics Market, by Product

6.1. Introduction
6.2. Assays & Reagents
6.3. Instruments & Devices
6.4. Software & Services

7. Respiratory Diagnostics Market, by Test Type

7.1. Introduction
7.2. Imaging Tests
7.2.1. Computed Tomography
7.2.2. Magnetic Resonance Imaging
7.2.3. Positron Emission Tomography
7.2.4. X-Ray
7.3. Mechanical Tests
7.3.1. Peak Flow Test
7.3.2. Pulmonary Function Tests
7.3.3. Spirometry
7.4. Molecular Diagnostic Tests
7.4.1. DNA Sequencing & Next-Generation Sequencing
7.4.2. In Situ Hybridization
7.4.3. Microarrays
7.4.4. Nucleic Acid Amplification Test
7.4.5. PCR
7.5. OSA Diagnostic Tests
7.6. Traditional Diagnostic Tests
7.6.1. Biochemical Tests
7.6.2. Immunodiagnostics
7.6.3. Microscopy

8. Respiratory Diagnostics Market, by Indication

8.1. Introduction
8.2. Asthma
8.3. Chronic Obstructive Pulmonary Disease
8.4. Lung Cancer
8.5. Pneumonia
8.6. Tuberculosis

9. Respiratory Diagnostics Market, by End-User

9.1. Introduction
9.2. Diagnostic Laboratories
9.3. Hospitals & Clinics
9.4. Research Institutes

10. Americas Respiratory Diagnostics Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Respiratory Diagnostics Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Respiratory Diagnostics Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. NYU Langone Health Enters 8-Year Partnership with Philips
13.3.2. Masimo Gets De Novo Approval From FDA for ORi
13.3.3. bioMérieux Submits Dual 510(k) and CLIA-Waiver Application to FDA for the BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel
13.3.4. BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
13.3.5. ResMed Acquires Sleep and Respiratory Diagnostics Software Maker Somnoware
13.3.6. Seegene Obtains IVDR Certification for 30 Diagnostic Assays
13.3.7. Hologic Announces FDA Clearance of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay
13.3.8. QIAGEN Launches QIAstat-Dx in Japan with Respiratory Panel for Syndromic Testing
13.3.9. Thermo Fisher partners with ALPCO-GeneProof to Broaden Their CE-IVD Molecular Assay Portfolio
13.3.10. Molbio Diagnostics adds Truenat H3N2/H1N1 Test to Respiratory Disease Portfolio
13.3.11. Vitalograph Launches New Respiratory VitaloPFT Series
13.3.12. SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience
13.3.13. Philips and Masimo Expand Partnership To Improve Telehealth For Patients And Clinicians Around The World

List of Figures

FIGURE 1. RESPIRATORY DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. RESPIRATORY DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. RESPIRATORY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. RESPIRATORY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. RESPIRATORY DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. RESPIRATORY DIAGNOSTICS MARKET DYNAMICS
TABLE 7. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ASSAYS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY X-RAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PEAK FLOW TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULMONARY FUNCTION TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OSA DIAGNOSTIC TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PNEUMONIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 73. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 74. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 75. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 76. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 77. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 81. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 82. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 83. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 84. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 85. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 107. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 108. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 109. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 110. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 115. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 116. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 117. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 118. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 119. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 123. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 124. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 125. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 126. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 127. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 131. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 132. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 133. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 134. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 135. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 139. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 140. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 141. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 142. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 143. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 147. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 148. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 149. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 150. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 151. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 152. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 155. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 156. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 157. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 158. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 159. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 160. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 163. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 164. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 165. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 166. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 167. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 168. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. SOUTH KOREA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. SOUTH KOREA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 171. SOUTH KOREA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 172. SOUTH KOREA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 173. SOUTH KOREA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 174. SOUTH KOREA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 175. SOUTH KOREA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 176. SOUTH KOREA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. TAIWAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. TAIWAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 179. TAIWAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 180. TAIWAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 181. TAIWAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 182. TAIWAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 183. TAIWAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 184. TAIWAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. THAILAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. THAILAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 187. THAILAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 188. THAILAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 189. THAILAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 190. THAILAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 191. THAILAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 192. THAILAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. VIETNAM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. VIETNAM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 195. VIETNAM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 196. VIETNAM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 197. VIETNAM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 198. VIETNAM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 199. VIETNAM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 200. VIETNAM RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 210. DENMARK RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. DENMARK RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 212. DENMARK RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 213. DENMARK RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 214. DENMARK RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 215. DENMARK RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 216. DENMARK RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 217. DENMARK RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. EGYPT RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. EGYPT RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 220. EGYPT RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 221. EGYPT RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 222. EGYPT RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 223. EGYPT RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 224. EGYPT RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 225. EGYPT RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. FINLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 227. FINLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 228. FINLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 229. FINLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 230. FINLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 231. FINLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 232. FINLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 233. FINLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 236. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 237. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 238. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 239. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 240. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 241. FRANCE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 243. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 244. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 245. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 246. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 247. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 248. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 249. GERMANY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 250. ISRAEL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 251. ISRAEL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 252. ISRAEL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 253. ISRAEL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 254. ISRAEL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 255. ISRAEL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 256. ISRAEL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 257. ISRAEL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 258. ITALY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 259. ITALY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 260. ITALY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 261. ITALY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 262. ITALY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 263. ITALY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 264. ITALY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 265. ITALY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 272. NETHERLANDS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 273. NETHERLANDS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 274. NIGERIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 275. NIGERIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 276. NIGERIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 277. NIGERIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 278. NIGERIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 279. NIGERIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 280. NIGERIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 281. NIGERIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 282. NORWAY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 283. NORWAY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 284. NORWAY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 285. NORWAY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 286. NORWAY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 287. NORWAY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 288. NORWAY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 289. NORWAY RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 290. POLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 291. POLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 292. POLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 293. POLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 294. POLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 295. POLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 296. POLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 297. POLAND RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 298. QATAR RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 299. QATAR RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 300. QATAR RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 301. QATAR RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 302. QATAR RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 303. QATAR RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 304. QATAR RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 305. QATAR RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 306. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 307. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 308. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 309. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 310. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 311. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 312. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 313. RUSSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 316. SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2030 (USD MILLION)
TABLE 318. SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2030 (USD MILLION)
TABLE 320. SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 322. SOUTH AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 324. SOUTH AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 325. SOUTH AFRIC

Companies Mentioned

The leading players in the Respiratory Diagnostics market, which are profiled in this report, include:

Adaltis S.r.l.
Masimo Corporation
Merck KGaA
Somnoware by ResMed Corp.
ProAxsis by NetScientific PLC
Medtronic PLC
Hologic, Inc.
F. Hoffmann-La Roche Ltd.
Quest Diagnostics Incorporated
Becton, Dickinson, and Company
Seegene Inc.
Siemens Healthineers AG
Abbott Laboratories
Vitalograph Ltd.
Bioneer Corporation
Altona Diagnostics GmbH
CerTest Biotec S.L.
GE HealthCare Technologies, Inc.
Drägerwerk AG & Co. KGaA
Quidel Corporation
Daan Gene Co., Ltd.
bioMérieux S.A.
SDI Diagnostics, Inc.
Koninklijke Philips N.V.
Bio-Rad Laboratories, Inc.
Sansure Biotech Inc.
Johnson & Johnson Services, Inc.
Thermo Fisher Scientific Inc.
ZeptoMetrix LLC
Diatech Pharmacogenetics srl

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	195
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 6.66 Billion
Forecasted Market Value ( USD ) by 2030	$ 10.96 Billion
Compound Annual Growth Rate	8.6%
Regions Covered	Global
No. of Companies Mentioned	30

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3391EUR$3,545USD£2,824GBP €3768EUR$3,939USD£3,137GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6000EUR$6,272USD£4,996GBP €6667EUR$6,969USD£5,551GBP

Understanding Market Dynamics in the Respiratory Diagnostics Market

Exploring Porter’s Five Forces for the Respiratory Diagnostics Market

Applying PESTLE Analysis to the Respiratory Diagnostics Market

Analyzing Market Share in the Respiratory Diagnostics Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Respiratory Diagnostics Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Respiratory Diagnostics Market Report by Product and Service Type, Test Type, Disease, End-User, and Region 2024-2032

Respiratory Diagnostics - Global Strategic Business Report

Global Respiratory Diagnostics Market: Focus on Disease Indication, Type, Test Type, End User, and Over 16 Countries' Data - Analysis and Forecast, 2024-2033

Global Respiratory Diagnostics Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

Respiratory Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F